K. Locher

Evolution of a mini-scale biphasic dissolution model: Impact of model parameters on partitioning of dissolved API and modelling of in vivo-relevant kinetics.

C. Kloft, K. Wagner, K. Frank, 2016, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Romosozumab Improves Bone Mass and Strength While Maintaining Bone Quality in Ovariectomized Cynomolgus Monkeys

Susan Y. Smith, S. Boyd, I. Pyrah, 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Molecular studies in 10 cases of Rubinstein-Taybi syndrome, including a mild variant showing a missense mutation in codon 1175 of CREBBP

E. Seemanová, G. Rödel, P. Meinecke, 2002, Journal of medical genetics.

Carcinogenicity risk assessment of romosozumab: A review of scientific weight-of-evidence and findings in a rat lifetime pharmacology study.

Susan Y. Smith, P. Mann, I. Pyrah, 2016, Regulatory toxicology and pharmacology : RTP.

Transition-metal compounds of two tetradentate pyrazole derivatives of piperazine

J. Reedijk, W. L. Driessen, K. Locher, 1987 .

Receptor binding by a ferret-transmissible H5 avian influenza virus

Yoshihiro Kawaoka, Xiaoli Xiong, Steven J. Gamblin, 2013, Nature.

Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture.

Yudong D. He, L. D. Ward, M. Guillot, 2020, Regulatory toxicology and pharmacology : RTP.

Differential time-dependent transcriptional changes in the osteoblast lineage in cortical bone associated with sclerostin antibody treatment in ovariectomized rats

R. Hu, I. Pyrah, R. Boyce, 2018, Bone reports.

Abstract 3364: Preclinical evaluation of BiTE®immune therapy targeting MUC17 or CLDN18.2 for gastric cancer

A. Henn, T. Raum, B. Rattel, 2020 .

In vivo predictive mini-scale dissolution for weak bases: Advantages of pH-shift in combination with an absorptive compartment.

Damir E Zecevic, Karl G Wagner, K. Wagner, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Decreased osteoprogenitor proliferation precedes attenuation of cancellous bone formation in ovariectomized rats treated with sclerostin antibody

I. Pyrah, R. Boyce, M. Ominsky, 2018, Bone reports.

Mechanistic study on hydrodynamics in the mini‐scale biphasic dissolution model and its influence on in vitro dissolution and partitioning

K. Wagner, K. Schaefer, J. M. Borghardt, 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.